Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
While GLP-1 agonists work well for controlling blood sugar and helping with weight loss, its important to remember that they arent suitable for everyone, including pregnant individuals or those with certain pre-existing health conditions, like a history of pancreatitis
We pair it with personalized, 1-on-1 coaching, a supportive community, and digital tools that help you build healthy habits for life
Scientific understanding continues to develop as further controlled laboratory and preclinical data becomes available
D., Tsintzas, K., & Thompson, D
GH Secretagogue Comparison Compound Class Receptor FDA Status Ipamorelin GHRP (ghrelin mimetic) GHS-R1a Not approved CJC-1295 GHRH analog GHRH-R Not approved Sermorelin GHRH analog GHRH-R Previously approved (Geref, discontinued) Tesamorelin GHRH analog GHRH-R FDA approved (Egrifta) GHRP-2 GHRP (ghrelin mimetic) GHS-R1a Not approved GHRP-6 GHRP (ghrelin mimetic) GHS-R1a Not approved Selectivity Profile: The Key Research Differentiator What makes Ipamorelin stand out among GHRPs is its endocrine selectivity
it is slightly invasive with little to no discomfort to the patient
US$ 20.54
US$ 27.91
US$ 24.33
US$ 25.80
US$ 28.10
US$ 23.26
